Pivotal bioVenture Partners

Pivotal bioVenture Partners

Pivotal bioVenture Partners

Suggest edits
Follow us
Also headquartered in San Francisco
Companies in the same industry
Terms of Service Privacy Policy Cookie Statement
Built with ❤︎ by Datalicious ©2022
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

News

Investments 10

Portfolio

Portfolio Tracker

Add info
Add round
28 Apr 2021
Exscientia
Exscientia
$225,000,000
Venture capital (Series D)
BlackRock, Casdin Capital, Farallon Capital Management, +8

AI Drug Developer Exscientia Closes $525M in Financing

neurons.AI
+1
01 Jul 2020
Bolt Biotherapeutics, Inc.
Bolt Biotherapeutics, Inc.
$93,500,000
Venture capital (Series C)
RA Capital Management, Rock Springs Capital, Vivo Capital, +6

Bolt Biotherapeutics Raises $93.5M in Series C Financing

FinSMEs
+1
31 Mar 2020
Akouos Inc
Akouos Inc
$105,000,000
Venture capital (Series B)
RA Capital Management, Novartis Venture Fund, Partners Innovation Fund, +8

Akouos Raises $105M in Series B Financing

FinSMEs
06 Mar 2020
SutroVax
SutroVax
$110,000,000
Venture capital (Series D)
Foresite Capital, RA Capital Management, Frazier Healthcare Partners, +7

SutroVax Raises $110M in Series D Financing

FinSMEs
03 Mar 2020
Akouos
Akouos
$105,000,000
Venture capital (Series B)
RA Capital Management, Novartis Venture Fund, Sofinnova Ventures, +7

Precision Genetic Medicine Company Akouos Secures $105 Million In Funding

Pulse 2.0
10 Apr 2019
Inozyme Pharma
Inozyme Pharma
$67,000,000
Venture capital (Series A)
RA Capital Management, Sofinnova Partners, NEA, +6

Inozyme Pharma Raises $67M in Series A2 Financing

FinSMEs
07 Jun 2018
SutroVax
SutroVax
$85,000,000
Venture capital (Series C)
Foresite Capital, TPG Growth, Abingworth, +6

SutroVax reels in $85 mln Series C

PE HUB
+1
04 Jan 2018
Oculis
Oculis
$20,300,000
Venture capital (Series B)
Novartis Venture Fund, Bay City Capital, Brunnur Ventures, +2

Oculis raises $20.3m Series B round to advance treatment for Ophthalmic Diseases

Norðurskautið
+1
19 May 2017
Iterum Therapeutics
Iterum Therapeutics
$65,000,000
Venture capital (Series B)
Canaan Partners, Frazier Healthcare Partners, New Leaf Venture Partners, +6

Iterum grabs $65 mln Series B

PE HUB
21 Mar 2017
SutroVax
SutroVax
$60,000,000
Venture capital (Series B)
Frazier Healthcare Partners, Abingworth, Roche Venture Fund, +3

SutroVax Announces Closing of $64M via Series B Financing

prnewswire